Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Women biopharma executives
Manufacturing
With ‘lessons learned,’ Kite preps for key CAR-T launch
Gilead's Kite is preparing to hit the ground running with the potential approval of a next-generation multiple myeloma cell therapy later this year.
Fraiser Kansteiner
Apr 28, 2026 11:30am
Argenx telegraphs CEO switch as chief drug Vyvgart rolls ahead
Jan 5, 2026 2:12pm
After year of change, Catalent embarks on corporate makeover
Oct 28, 2025 12:02am
Argenx banks on Vyvgart prefilled syringe approval in 2025: exec
Feb 19, 2025 1:36pm
For CDMOs, employment and funding hitches persist after pandemic
Jan 8, 2024 10:52am
Genentech elevates interim CEO to full-time leadership position
Dec 12, 2023 4:12pm
